Year: 2021
-
Expansion of 2GETHER Project Awarded $9 Million
The Institute for Sexual and Gender Minority Health and Wellbeing has been awarded a five-year, $9 million for the expansion of the 2GETHER study, which aims to reduce HIV incidence by teaching relationship and sexual health promotion skills to young men who have sex with men.
-
Protein Variant May Have Potential as Target for Glioblastoma
Inhibiting a novel protein variant within glioma stem cells may be a promising therapeutic approach to treat glioblastoma, according to a recent Northwestern Medicine study.
-
Feinberg Investigators Discuss Impact and Evolution of COVID-19
It’s been one year since the first case of COVID-19 was detected in the United States, and still Feinberg investigators continue to investigate the disease, its evolution and its impact on society.
-
‘Sweat Sticker’ Diagnoses Cystic Fibrosis on The Skin in Real Time
Developed by Northwestern scientists, a novel skin-mounted sticker that absorbs sweat and then changes color can provide an accurate, easy-to-read diagnosis of cystic fibrosis within minutes.
-
Examining Rare Neurological Complications of COVID-19 in Children
The largest study to date of neurological manifestations of COVID-19 in children demonstrated patterns in the rare complications seen among pediatric patients.
-
Bioinformatic Computational Tool Analyzes Tissue Samples to Discern Disease
A novel integrative computational technique allowed scientists to classify disease conditions at the molecular level using epigenomic data sets.
-
Feinberg Rises to 15th in U.S. News Ranking for Research-Oriented Medical Schools
Northwestern University Feinberg School of Medicine has been recognized as one of the best research-oriented medical schools in the nation, rising three spots to rank an all-time high of 15th, according to the latest U.S. News & World Report rankings, released today.
-
Inflammation Protection May Be Critical to Treating MS
Prolonging a cellular defense response to inflammation could help regenerate the protective coating of axons that is degraded in diseases such as multiple sclerosis, according to a recent study.
-
Northwestern Scientists Discover Potential Therapeutic Target for Glioblastoma
Northwestern Medicine investigators have discovered that inhibiting tumor-associated myeloid cells ability to produce specialized metabolites called polyamines may improve the effectiveness of treatments for glioblastoma.
-
Antibody Bolsters Immune Response to Glioblastoma
Northwestern Medicine scientists have engineered a novel antibody that revitalizes immune cell activity in a deadly brain cancer, according to a recent study.
